Bayer’s $7.25B Roundup settlement gains initial approval in Missouri, potentially resolving thousands of cancer lawsuits tied to glyphosate exposure.
Autism researchers form an independent panel to defend evidence-based science amid controversy over changes to the U.S. federal autism advisory committee.
CDC faces leadership exodus amid policy disputes, raising concerns over scientific independence and outbreak readiness.
Major talcum powder verdicts are reshaping corporate liability, public health debates, and mass tort litigation nationwide.
A Single Shot to Shield Against Two Viruses: EMA Poised to Approve Moderna’s COVID-Flu Combo Vaccine
EMA backs Moderna’s dual COVID-19 and flu vaccine, mCombriax, paving the way for EU approval ahead of the 2026–2027 season.
Severe heart attack deaths are rising among Americans under 55, especially women. Experts warn of shifting risks and ...
Brazil explores using surplus solar power for Bitcoin mining, turning renewable energy waste into economic opportunity.
Novo Nordisk slashes U.S. prices for Ozempic and Wegovy by up to 50%, reshaping access to diabetes and weight-loss care.
Casey Means’ Surgeon General nomination sparks debate over vaccines, chronic disease policy, and the future of U.S. public health.
How social media affects teens’ mental health, sleep, and self-esteem — plus expert guidance for parents navigating digital ...
New data show abortion clinic closures in 2026, even in legal states, reshaping reproductive health access across the U.S.
Mexico’s escalating cartel violence leaves over 70 dead, disrupting daily life, tourism, and regional economic stability.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results